C

Catalyst Pharmaceuticals
D

CPRX

23.530
USD
0.45
(1.95%)
مغلق
حجم التداول
40,136
الربح لكل سهم
2
العائد الربحي
-
P/E
14
حجم السوق
2,892,128,466
أصول ذات صلة الأخبار المقالات
المزيد

العنوان: Catalyst Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).